A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1

被引:15
|
作者
Fitzjohn, Stephen M. [1 ]
Kuenzi, Frederick [1 ,2 ]
Morton, Robin A. [1 ,2 ]
Rosahl, Thomas W. [2 ,3 ]
Lewis, Huw [2 ]
Smith, David [2 ]
Seabrook, Guy R. [1 ,2 ,4 ]
Collingridge, Graham L. [1 ]
机构
[1] Univ Bristol, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England
[2] Merck Sharp & Dohme Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England
[3] Merck Res Labs, Rahway, NJ 07065 USA
[4] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
来源
MOLECULAR BRAIN | 2010年 / 3卷
基金
英国医学研究理事会;
关键词
Amyloid Precursor Protein; Kynurenic Acid; Theta Burst Stimulation; Basal Synaptic Transmission; fEPSP Slope;
D O I
10.1186/1756-6606-3-21
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Synaptic transmission and long-term potentiation (LTP) in the CA1 region of hippocampal slices have been studied during ageing of a double transgenic mouse strain relevant to early-onset familial Alzheimer's disease (AD). This strain, which over-expresses both the 695 amino acid isoform of human amyloid precursor protein (APP) with K670N and M671L mutations and presenilin 1 with the A246E mutation, has accelerated amyloidosis and plaque formation. There was a decrease in synaptic transmission in both wildtype and transgenic mice between 2 and 9 months of age. However, preparing slices from 14 month old animals in kynurenic acid (1 mM) counteracted this age-related deficit. Basal transmission and paired-pulse facilitation was similar between the two groups at all ages (2, 6, 9 and 14 months) tested. Similarly, at all ages LTP, induced either by theta burst stimulation or by multiple tetani, was normal. These data show that a prolonged, substantially elevated level of A beta are not sufficient to cause deficits in the induction or expression of LTP in the CA1 hippocampal region.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
    Leigh Holcomb
    Marcia N. Gordon
    Eileen McGowan
    Xin Yu
    Stan Benkovic
    Paul Jantzen
    Kristal Wright
    Irene Saad
    Ryan Mueller
    Dave Morgan
    Sunny Sanders
    Cindy Zehr
    Kassandra O'Campo
    John Hardy
    Cristian-Mihail Prada
    Chris Eckman
    Steve Younkin
    Karen Hsiao
    Karen Duff
    Nature Medicine, 1998, 4 : 97 - 100
  • [22] Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
    Holcomb, L
    Gordon, MN
    McGowan, E
    Yu, X
    Benkovic, S
    Jantzen, P
    Wright, K
    Saad, I
    Mueller, R
    Morgan, D
    Sanders, S
    Zehr, C
    O'Campo, K
    Hardy, J
    Prada, CM
    Eckman, C
    Younkin, S
    Hsiao, K
    Duff, K
    NATURE MEDICINE, 1998, 4 (01) : 97 - 100
  • [23] Transgenic mice expressing mutant and wild type human presenilin-1 (PS-1)
    Frosch, MP
    Collins, T
    Zhang, J
    Ahn, P
    Berezovskaja, O
    Xia, M
    Hyman, BT
    Koo, EH
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (05): : 1 - 1
  • [24] Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice
    Wirths, O
    Multhaup, G
    Czech, C
    Blanchard, V
    Moussaoui, S
    Tremp, G
    Pradier, L
    Beyreuther, K
    Bayer, TA
    NEUROSCIENCE LETTERS, 2001, 306 (1-2) : 116 - 120
  • [25] Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes
    Howlett, DR
    Richardson, JC
    Austin, A
    Parsons, AA
    Bate, ST
    Davies, DC
    Gonzalez, MI
    BRAIN RESEARCH, 2004, 1017 (1-2) : 130 - 136
  • [26] Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice
    Dewachter, I
    Reversé, D
    Caluwaerts, N
    Ris, L
    Kuipéri, C
    Van den Haute, C
    Spittaels, K
    Umans, L
    Serneels, L
    Thiry, E
    Moechars, D
    Mercken, M
    Godaux, E
    Van Leuven, F
    JOURNAL OF NEUROSCIENCE, 2002, 22 (09): : 3445 - 3453
  • [27] TASTPM Mice Expressing Amyloid Precursor Protein and Presenilin-1 Mutant Transgenes Are Sensitive to γ-Secretase Modulation and Amyloid-β42 Lowering by GSM-10h
    Hussain, Ishrut
    Harrison, David C.
    Hawkins, Julie
    Chapman, Trevor
    Marshall, Ian
    Facci, Laura
    Ahmed, Sharlin
    Brackenborough, Kim
    Skaper, Stephen D.
    Mead, Tania L.
    Smith, Beverley B.
    Giblin, Gerard M. P.
    Hall, Adrian
    Gonzalez, M. Isabel
    Richardson, Jill C.
    NEURODEGENERATIVE DISEASES, 2011, 8 (1-2) : 15 - 24
  • [28] Effect of Selenium Treatment on Central Insulin Sensitivity: A Proteomic Analysis in β-Amyloid Precursor Protein/Presenilin-1 Transgenic Mice
    Xu, Xia
    Qi, Pishui
    Zhang, Ying
    Sun, Huihuan
    Yan, Yong
    Sun, Wenxiu
    Liu, Shudong
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [29] Age-related amyloid β deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid β precursor protein Swedish mutant is not associated with global neuronal loss
    Takeuchi, A
    Irizarry, MC
    Duff, K
    Saido, TC
    Ashe, KH
    Hasegawa, M
    Mann, DMA
    Hyman, BT
    Iwatsubo, T
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (01): : 331 - 339
  • [30] Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
    Borchelt, DR
    Ratovitski, T
    vanLare, J
    Lee, MK
    Gonzales, V
    Jenkins, NA
    Copeland, NG
    Price, DL
    Sisodia, SS
    NEURON, 1997, 19 (04) : 939 - 945